Logo

Amersham Pharmacia Gets NHGRI Grant for Genomic Technology Development

Jan 28, 2000
Premium

S

UNNYVALE, Calif.--Amersham Pharmacia Biotech has been awarded a grant by the US National Human Genome Research Institute under a new program called Advanced Development of Genomic Technologies that is emphasizing DNA sequencing technologies. Amersham will work with researchers from Northeastern University in Boston and Washington University School of Medicine in St. Louis to develop a new generation of DNA sequencers.

Filed under

Informatics
Breaking News
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.